Conn. Attorney General Launches Anitrust Probe of Purdue

Law360, New York (January 7, 2004, 12:00 AM EST) -- A day after a federal judge found that Purdue Pharma's patents protecting its OxyContin painkiller were invalid because the company deliberately misled the U.S. Patent and Trademark Office, Connecticut's Attorney General said he would ask other states to join in an antitrust investigation to determine whether Purdue blocked the development of cheaper generic alternatives.

Connecticut Attorney General Richard Blumenthal said U.S. District Judge Sidney H. Stein’s ruling offers strong evidence that the company may have deprived consumers of more affordable alternatives.

Blumenthal, who was already investigating...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.